Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Strayer Insider Profile
4 Followers
David Strayer, Chief Science/Medical Officer at AIM ImmunoTech, holds 5.42K shares in AIM ImmunoTech (Ticker: AIM). Most recently, David Strayer Bought $2,481 shares of AIM ImmunoTech on Jun 25, 2019 for an estimated value of 10.00K.
David Strayer AIM ImmunoTech (AIM)Chief Science/Medical Officer
AIM ImmunoTech (AIM)
Chief Science/Medical Officer
Ranked #81,025 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-32.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Science/Medical Officer
Roles that David Strayer holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Strayer
David Strayer's Trading History
List of latest transactions for each holding click on a transaction to see David Strayer's performance on stock
You May Also Like
David Strayer insider profile FAQ
What is the percentage of profitable transactions made by David Strayer?
The percentage of profitable transactions made by David Strayer is 0%.
What is the average return per transaction made by David Strayer?
The average return per transaction made by David Strayer is -32.80%.
What stocks does David Strayer hold?
David Strayer holds: AIM stocks.
What was David Strayer’s latest transaction?
David Strayer latest transaction was an Informative Buy of $10.00K.
What was David Strayer's most profitable transaction?
David Strayer’s most profitable transaction was an Informative Buy of AIM stock on February 21, 2017. The return on the trade was -4.20%.
What is David Strayer's role in AIM ImmunoTech?
David Strayer's role in AIM ImmunoTech is Chief Science/Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.